Stoke Therapeutics, Inc. ($STOK)
Filing Information
| Accession Number | 0001762572-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 17, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
20,000
Total Value
$0.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Patient Officer | Common Stock | โ | Mar 15, 2026 | Exercise/Conversion | 10,000 | $0.00 | $0.00 | 13,988 | Direct | โ | View Details | |
Chief Patient Officer | Restricted Stock Units | Derivative | Mar 15, 2026 | Exercise/Conversion | 10,000 | $0.00 | $0.00 | 30,000 | Direct | โ | View Details |